Sakar Healthcare Ltd.

₹518.75

-38 (-6.8%)

SAKAR Share Price

Pharmaceuticals & Biotechnology

As on March 13, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 1,164 Cr

P/E Ratio65.06

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	538.61	Bearish
10-DMA	528.92	Bearish
20-DMA	510.16	Bullish
50-DMA	449.46	Bullish
100-DMA	419.7	Bullish
200-DMA	380.94	Bullish

Historical Performance

1 Year

117.3%

3 Years

129.5%

5 Years

469.1%

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	1,776	1,534	1,334	1,282	947
Total Expenditure	1,279	1,150	1,001	989	721
Other Income	13	32	47	22	12
Operating Profit	510	416	379	315	238
Interest	86	76	60	29	25
Depreciation	209	181	150	97	81
Profit Before Tax	215	159	170	189	132
Consolidated Net Profit	175	117	128	152	107
Adjusted EPS	8	5	7	9	7

Compounded Sales Growth

10 Years:16.4

5 Years:16.4

3 Years:6.7

TTM:3

Compounded Profit Growth

10 Years:12.7

5 Years:12.7

3 Years:2.9

TTM:8.4

Stock Price CAGR

10 Years:N/A

5 Years:40.6

3 Years:31.9

TTM:117.4

Return on Equity

10 Years:N/A

5 Years:6.8

3 Years:6.7

last year:8

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	219	217	190	171	156
Total Reserves	2,606	2,358	1,543	1,103	828
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	666	673	1,085	935	461
Other Current Liabilities	194	163	136	86	88
Short Term Borrowings	214	139	130	45	17
Total Liabilities	4,153	3,887	3,363	2,678	1,778
Capital Work in Progress	167	3	65	12	489
Long Term Loans & Advances	9	24	73	119	260
Currents Investments	---	---	34	71	---
Short Term Loans and Advances	138	216	145	143	55
Total Current Assets	887	716	559	500	337
Total Assets	4,153	3,887	3,363	2,678	1,778
Adjusted Book Value	129	118	91	74	63

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 65.06, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 31.9%, indicating sustained price appreciation.
The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹510 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹1776 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 2196883.1

No. of Shares: 4235 (Approx)

Performance:119.7%

P/L: ₹1196883.1

NIFTY Performance: 3.4%

1 day Top Gainers